We are live on
!
Find out more
ICM
Invenomic Capital Management Portfolio holdings
AUM
$2.18B
1-Year Est. Return
0.03%
This Fund
S&P 500
This Quarter
Est. Return
-10.56%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$1.98B
AUM Growth
-$122M
(-5.8%)
Cap. Flow
+$122M
Cap. Flow
% of AUM
6.17%
Top 10 Holdings %
Top 10 Hldgs %
22.19%
Holding
209
New
50
Increased
69
Reduced
49
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teleflex
TFX
|
+$52.1M |
| 2 |
Warner Bros
WBD
|
+$34M |
| 3 |
Viatris
VTRS
|
+$33.3M |
| 4 |
Iovance Biotherapeutics
IOVA
|
+$28.3M |
| 5 |
Akamai
AKAM
|
+$27.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Molson Coors Class B
TAP
|
+$37.4M |
| 2 |
Eversource Energy
ES
|
+$34.8M |
| 3 |
AT&T
T
|
+$30M |
| 4 |
SS&C Technologies
SSNC
|
+$28M |
| 5 |
Progyny
PGNY
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.24% |
| 2 | Consumer Discretionary | 18.14% |
| 3 | Healthcare | 12.54% |
| 4 | Industrials | 8.78% |
| 5 | Communication Services | 8.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Vail Resorts
MTN
$5.21B
| $2.17M | 0.11% |
+13,582
| New | +$2.26M |
|
|
LOVE
152
LoveSac
LOVE
$253M
| $2.14M | 0.11% |
+117,896
| New | +$2.58M |
|
153
Rapid7
RPD
$776M
| $2.1M | 0.11% |
+79,049
| New | +$2.69M |
|
154
Lightspeed Commerce
LSPD
$1.36B
| $1.96M | 0.1% |
+224,288
| New | +$2.89M |
|
|
AVDL
155
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.79M | 0.09% |
+228,026
| New | +$1.91M |
|
|
TBI
156
Trueblue
TBI
$323M
| $1.73M | 0.09% |
326,262
-15,121
| -4% | -$103K |
|
|
CADE
157
PUT
DELISTED
Cadence Bank
CADE
| $1.52M | 0.08% |
50,000
| – | – |
|
158
RE/MAX Holdings
RMAX
$243M
| $1.47M | 0.07% |
+175,403
| New | +$1.67M |
|
159
DMC Global
BOOM
$153M
| $1.44M | 0.07% |
171,259
-25,030
| -13% | -$204K |
|
160
DoubleVerify
DV
$2.03B
| $1.34M | 0.07% |
+100,000
| New | +$1.85M |
|
161
Domo
DOMO
$189M
| $1.33M | 0.07% |
171,853
-48,622
| -22% | -$389K |
|
162
Koppers
KOP
$956M
| $1.14M | 0.06% |
+40,828
| New | +$1.23M |
|
163
GrafTech
EAF
$205M
| $1.09M | 0.06% |
125,189
-18,252
| -13% | -$237K |
|
164
RLJ Lodging Trust
RLJ
$1.67B
| $1.06M | 0.05% |
134,070
-750,958
| -85% | -$7.05M |
|
165
Array Technologies
ARRY
$819M
| $984K | 0.05% |
202,000
-1,730,203
| -90% | -$11.1M |
|
166
Lexaria Bioscience
LEXX
$9.07M
| $940K | 0.05% |
36,663
+9,281
| +34% | +$236K |
|
167
ScottsMiracle-Gro
SMG
$3.63B
| $924K | 0.05% |
+16,830
| New | +$1.09M |
|
168
Johnson Outdoors
JOUT
$501M
| $860K | 0.04% |
34,617
-8,531
| -20% | -$249K |
|
|
LAND
169
Gladstone Land Corp
LAND
$351M
| $638K | 0.03% |
+60,646
| New | +$664K |
|
170
Purple Innovation
PRPL
$39.6M
| $577K | 0.03% |
30,398
-1,409
| -4% | -$32.5K |
|
171
PetMed Express
PETS
$42.1M
| $485K | 0.02% |
115,740
-32,682
| -22% | -$148K |
|
172
Tactile Systems Technology
TCMD
$657M
| $296K | 0.01% |
+22,390
| New | +$352K |
|
173
Black Hills Corp
BKH
$5.62B
| – | – |
-146,171
| Closed | -$8.55M |
|
174
Conagra Brands
CAG
$7.07B
| – | – |
-225,792
| Closed | -$6.27M |
|
175
Cannae Holdings
CNNE
$644M
| – | – |
-512,294
| Closed | -$10.2M |
|
Similar funds
SIG
ORCP
ET
GC
MIAS
TAL
IIP
WCMNY
Invenomic Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, Invenomic Capital Management held 209 positions worth $1.98B, down 5.8% from $2.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Invenomic Capital Management deployed $122M of net new capital in Q1 2025, opening 50 new positions and adding to 69 existing holdings. Its largest new stake was Warner Bros: 3,254,123 shares worth $34.9M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Eversource Energy, an estimated $34.8M trimmed.
- Invenomic Capital Management's largest Q1 2025 buy was Warner Bros: 3,254,123 shares worth $34.9M.
- Invenomic Capital Management added most to Teleflex in Q1 2025, an estimated $52.1M increase.
- Invenomic Capital Management's biggest Q1 2025 reduction was Eversource Energy, cutting an estimated $34.8M.
- Invenomic Capital Management fully exited Molson Coors Class B in Q1 2025, selling an estimated $37.4M.
- Invenomic Capital Management's ten largest holdings make up 22% of its $1.98B portfolio in Q1 2025.
- Invenomic Capital Management opened 50 new positions and closed 37 in Q1 2025.
- Invenomic Capital Management's portfolio value fell 5.8% quarter-over-quarter to $1.98B.
Based on Invenomic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.